Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Panchsheel Organics Ltd (PANCHSHEEL) Share Price & Fundamentals

Company Overview

Founded Year

1989

Listed Year

1992

Headquarter

Indore, Madhya Pradesh, India

MD/CEO

-

Website

https://panchsheelorganics.com

Company Facts

What we do

Panchsheel Organics Ltd manufactures and exports Active Pharma Ingredients, Intermediates, and Finished Formulations for human and veterinary use, emphasizing technology-driven pharma products.

Founded in

1,989

Market share

A reputed player in the Indian pharma export market with a 35+ year legacy in APIs and formulations.

Problem solved

Provides high-quality, life-saving pharmaceutical ingredients and formulations addressing critical health needs globally.

Top clients or who we serve

Pharmaceutical manufacturers and healthcare sectors worldwide; B2B export-focused model.

Key management

-

Our journey and innovations

Founded in 1989, expanded manufacturing with three units including subsidiaries; specializes in complex chemical processes in APIs and formulations.

Where we operate

Primarily India with export markets internationally.

Top products or what we offer

Cardiovascular, neuropsychiatry, antifungal, fluoroquinolones, anti-inflammatory APIs and formulations.

Top brands

No distinct consumer brands; known for specialty pharma ingredients and formulations across multiple therapy areas.

Raw materials needed

Chemical intermediates, specialty chemicals, hormones, steroids, raw materials for pharma synthesis.

Raw materials supplier

Sourced globally and indigenously, details unspecified.

Recurring vs cyclical contribution

Revenue mainly from recurring B2B pharmaceutical contracts with some market cyclicality.

Our industry position

Established exporter with strong manufacturing capabilities in API and formulation segments.

Financial highlights

FY 2024-25 revenue approx. INR 110 crore with net profit approx. INR 13.79 crore, steady growth year-on-year.

Geographical revenue split

About 98.7% revenue from India and 1.3% from international markets as of FY 2022-23.

Order book

-

Whats driving growth

Growing pharma exports, product diversification, process innovation, and expanded manufacturing capacity.

Our future plans

Ongoing focus on capacity utilization, enhancing product portfolio, and new director appointments.

Our green promise

-

Our people and values

Dedicated workforce with emphasis on talent growth, inclusive culture, and employee welfare.

Key challenges ahead

Managing regulatory compliance, competition, and raw material sourcing risks.

Interesting facts

Operates multiple specialized plants in Indore with strong governance and no deposit acceptance.

Risks and strategy

Risk management framework in place covering operational and compliance risks; focus on transparency and business continuity.

Market Footprint

Top Clients

Top Clients

Pharmaceutical manufacturers and healthcare sectors worldwide; B2B export-focused model.

Top Products

Top Products

Cardiovascular, neuropsychiatry, antifungal, fluoroquinolones, anti-inflammatory APIs and formulations.

Price Movement & Share Holding

Today's High/Low

100.9103.7

52 Week High/Low

86.1154.4
Past Returns

1 week

0.97%

1 month

-1.05%

3 month

-13.58%

1 year

-26.09%

3 year

-40.93%

5 year

24.12%

Share Holding

Promoters

56.12%

FII

0%

DII

0%

Retail

39.2%

Others

4.67%

Company Overview

Founded Year

1989

Listed Year

1992

Headquarter

Indore, Madhya Pradesh, India

MD/CEO

-

Website

https://panchsheelorganics.com

Price Movement & Share Holding

Today's High/Low

100.9103.7

52 Week High/Low

86.1154.4

Past Returns

1 week

0.97%

1 month

-1.05%

3 month

-13.58%

1 year

-26.09%

3 year

-40.93%

5 year

24.12%

Share Holding

Promoters

56.12%

FII

0%

DII

0%

Retail

39.2%

Others

4.67%

Company Facts

What we do

Panchsheel Organics Ltd manufactures and exports Active Pharma Ingredients, Intermediates, and Finished Formulations for human and veterinary use, emphasizing technology-driven pharma products.

Founded in

1989

Market share

A reputed player in the Indian pharma export market with a 35+ year legacy in APIs and formulations.

Problem solved

Provides high-quality, life-saving pharmaceutical ingredients and formulations addressing critical health needs globally.

Top clients or who we serve

Pharmaceutical manufacturers and healthcare sectors worldwide; B2B export-focused model.

Our journey and innovations

Founded in 1989, expanded manufacturing with three units including subsidiaries; specializes in complex chemical processes in APIs and formulations.

Where we operate

Primarily India with export markets internationally.

Top products or what we offer

Cardiovascular, neuropsychiatry, antifungal, fluoroquinolones, anti-inflammatory APIs and formulations.

Top brands

No distinct consumer brands; known for specialty pharma ingredients and formulations across multiple therapy areas.

Raw materials needed

Chemical intermediates, specialty chemicals, hormones, steroids, raw materials for pharma synthesis.

Raw materials supplier

Sourced globally and indigenously, details unspecified.

Recurring vs cyclical contribution

Revenue mainly from recurring B2B pharmaceutical contracts with some market cyclicality.

Our industry position

Established exporter with strong manufacturing capabilities in API and formulation segments.

Financial highlights

FY 2024-25 revenue approx. INR 110 crore with net profit approx. INR 13.79 crore, steady growth year-on-year.

Geographical revenue split

About 98.7% revenue from India and 1.3% from international markets as of FY 2022-23.

Whats driving growth

Growing pharma exports, product diversification, process innovation, and expanded manufacturing capacity.

Our future plans

Ongoing focus on capacity utilization, enhancing product portfolio, and new director appointments.

Our people and values

Dedicated workforce with emphasis on talent growth, inclusive culture, and employee welfare.

Key challenges ahead

Managing regulatory compliance, competition, and raw material sourcing risks.

Interesting facts

Operates multiple specialized plants in Indore with strong governance and no deposit acceptance.

Risks and strategy

Risk management framework in place covering operational and compliance risks; focus on transparency and business continuity.

Market Footprint

Top Clients

Top Clients

Pharmaceutical manufacturers and healthcare sectors worldwide; B2B export-focused model.

Top Products

Top Products

Cardiovascular, neuropsychiatry, antifungal, fluoroquinolones, anti-inflammatory APIs and formulations.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions